Skip to content
Smart Money

Pharmaceuticals

BFBIO BF Biosciences Limited

Latest results: FY2026 · Jun 2026

Last close · 16 Oct 2026

Rs 128.65 -0.96%

Quarterly · Q4 FY2023 – Q4 FY2026

BF Biosciences Limited (BFBIO) quarterly balance sheet

BFBIO balance sheet (quarterly) (Rs bn)
Rs bn Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023 Q4 FY2023 Apr – Jun 2023
Assets
Cash & short-term investments — 0.8 1.7 1.6 1.5 1.3 2.0 1.9 0.3 0.4 — — —
Trade receivables — 0.6 0.6 0.6 0.2 0.4 0.3 0.5 0.2 0.2 — — —
Inventories 3.3 2.7 2.7 1.8 1.8 1.8 1.5 1.1 0.9 0.9 — — —
Other current assets 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.1 — — —
Total current assets — 4.6 5.5 4.4 3.8 3.9 4.1 3.9 1.7 1.7 — — —
Property, plant & equipment — 4.5 4.4 4.3 4.3 4.2 4.3 4.3 4.2 4.1 — — —
Intangible assets — 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — — —
Other non-current assets — 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — — —
Total non-current assets — 4.6 4.5 4.3 4.3 4.3 4.3 4.3 4.2 4.2 — — —
Total assets — 9.2 10.0 8.7 8.2 8.2 8.4 8.2 5.9 5.9 — — —
Liabilities
Trade payables 0.3 1.6 2.6 1.4 0.3 1.1 1.2 1.1 0.3 0.3 — — —
Short-term borrowings & current portion of debt — 0.6 0.4 0.5 0.4 0.3 0.6 0.7 0.6 0.5 — — —
Total current liabilities — 2.3 3.2 2.1 1.6 1.6 2.0 3.7 1.4 1.4 — — —
Long-term debt — 1.2 1.2 1.3 1.4 1.5 1.5 1.6 1.6 1.7 — — —
Other non-current liabilities — 0.2 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 — — —
Total non-current liabilities — 1.7 1.8 1.9 1.9 2.0 2.0 2.0 2.1 2.2 — — —
Total liabilities — 4.1 5.0 3.9 3.5 3.6 4.0 5.7 3.5 3.6 — — —
Equity
Share capital — 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 — — —
Reserves & retained earnings — 3.1 3.0 2.8 2.6 2.5 2.4 2.3 2.2 2.1 — — —
Equity attributable to shareholders — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — — —
Non-controlling interest — 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — — —
Total equity — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — — —
Total liabilities & equity — 9.2 10.0 8.7 8.2 8.2 8.4 8.2 5.9 5.9 — — —
Key figures
Total debt — 1.7 1.6 1.8 1.7 1.9 2.1 2.3 2.2 2.2 — — —
Net debt / (net cash) — 0.9 (0.1) 0.3 0.2 0.5 0.1 0.4 1.9 1.8 — — —
Shares outstanding mn — 88.3 88.3 88.3 88.3 88.3 88.3 88.3 63.3 63.3 — — —
Common equity — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — — —
Book value per share (Rs) Rs — 58.04 56.71 54.58 52.78 51.34 49.93 28.02 37.26 36.13 — — —
BFBIO balance sheet — year-on-year change (Rs mn)
Rs mn Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023 Q4 FY2023 Apr – Jun 2023
Assets
Cash & short-term investments — -37.2% -13.9% -18.6% +375.6% +245.4% — — — — — — —
Trade receivables — +69.7% +122.2% +20.3% -10.0% +51.8% — — — — — — —
Inventories +78.7% +48.9% +81.4% +57.5% +101.6% +100.1% — — — — — — —
Other current assets -97.8% -44.9% +118.1% -72.9% -51.1% +51.1% — — — — — — —
Total current assets — +18.2% +36.1% +13.2% +128.8% +128.4% — — — — — — —
Property, plant & equipment — +5.6% +2.3% +1.1% +3.1% +2.3% — — — — — — —
Intangible assets — -40.6% -38.8% +756.9% +619.8% +557.5% — — — — — — —
Other non-current assets — +882.7% +894.3% +9.4% +51.4% -62.0% — — — — — — —
Total non-current assets — +7.1% +3.9% +1.2% +3.3% +2.1% — — — — — — —
Total assets — +12.4% +19.5% +6.9% +39.2% +38.9% — — — — — — —
Liabilities
Trade payables -10.2% +46.7% +112.5% +24.0% +19.3% +291.2% — — — — — — —
Short-term borrowings & current portion of debt — +70.9% -25.4% -29.2% -42.5% -35.5% — — — — — — —
Total current liabilities — +44.1% +64.3% -44.0% +13.7% +12.7% — — — — — — —
Long-term debt — -23.4% -20.5% -16.0% -14.0% -10.2% — — — — — — —
Other non-current liabilities — -30.2% -28.8% -27.6% -26.4% -25.3% — — — — — — —
Total non-current liabilities — -14.4% -11.7% -8.2% -9.6% -6.6% — — — — — — —
Total liabilities — +11.6% +26.0% -31.3% -0.1% +1.1% — — — — — — —
Equity
Share capital — 0.0% 0.0% +39.5% +39.5% +39.5% — — — — — — —
Reserves & retained earnings — +23.8% +25.3% +21.5% +20.6% +18.7% — — — — — — —
Equity attributable to shareholders — +13.0% +13.6% +94.8% +97.6% +98.2% — — — — — — —
Non-controlling interest — — — — — — — — — — — — —
Total equity — +13.0% +13.6% +94.8% +97.6% +98.2% — — — — — — —
Total liabilities & equity — +12.4% +19.5% +6.9% +39.2% +38.9% — — — — — — —
Key figures
Total debt — -6.8% -21.8% -20.0% -22.0% -16.0% — — — — — — —
Net debt / (net cash) — +69.5% -210.2% -27.3% -88.7% -71.1% — — — — — — —
Shares outstanding — — — — — — — — — — — — —
Common equity — +13.0% +13.6% +94.8% +97.6% +98.2% — — — — — — —
Book value per share (Rs) — +13.0% +13.6% +94.8% +41.7% +42.1% — — — — — — —

Change against the same quarter a year earlier; shown when the earlier figure is positive.

BFBIO balance sheet — common size (Rs mn)
Rs mn Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023 Q4 FY2023 Apr – Jun 2023
Assets
Cash & short-term investments — 9.1% 17.1% 17.8% 18.5% 16.2% 23.8% 23.3% 5.4% 6.5% — — —
Trade receivables — 6.5% 6.0% 6.5% 2.3% 4.3% 3.2% 5.8% 3.5% 3.9% — — —
Inventories — 29.8% 26.8% 20.5% 22.4% 22.5% 17.7% 13.9% 15.4% 15.6% — — —
Other current assets — 0.7% 1.7% 1.0% 0.7% 1.4% 0.9% 3.9% 2.0% 1.3% — — —
Total current assets — 50.3% 55.2% 50.5% 47.0% 47.9% 48.5% 47.7% 28.6% 29.1% — — —
Property, plant & equipment — 48.8% 44.0% 49.3% 52.8% 52.0% 51.4% 52.1% 71.2% 70.5% — — —
Intangible assets — 0.0% 0.0% 0.0% 0.0% 0.1% 0.1% 0.0% 0.0% 0.0% — — —
Other non-current assets — 0.8% 0.8% 0.1% 0.1% 0.1% 0.1% 0.1% 0.1% 0.4% — — —
Total non-current assets — 49.7% 44.8% 49.5% 53.0% 52.1% 51.5% 52.3% 71.4% 70.9% — — —
Total assets — 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% — — —
Liabilities
Trade payables — 17.7% 25.7% 16.2% 3.9% 13.5% 14.4% 13.9% 4.6% 4.8% — — —
Short-term borrowings & current portion of debt — 6.1% 4.2% 5.5% 4.4% 4.0% 6.7% 8.3% 10.6% 8.6% — — —
Total current liabilities — 25.3% 32.4% 23.5% 19.9% 19.8% 23.5% 44.9% 24.4% 24.4% — — —
Long-term debt — 12.7% 12.1% 15.2% 16.8% 18.7% 18.1% 19.4% 27.1% 28.9% — — —
Other non-current liabilities — 2.6% 2.7% 3.3% 3.9% 4.2% 4.5% 4.9% 7.4% 7.9% — — —
Total non-current liabilities — 18.8% 17.7% 21.3% 22.9% 24.7% 23.9% 24.8% 35.4% 36.7% — — —
Total liabilities — 44.2% 50.1% 44.8% 42.9% 44.5% 47.5% 69.7% 59.7% 61.1% — — —
Equity
Share capital — 2.9% 2.6% 3.0% 3.2% 3.2% 3.2% 2.3% 3.2% 3.2% — — —
Reserves & retained earnings — 33.6% 29.6% 31.8% 32.1% 30.5% 28.2% 28.0% 37.0% 35.7% — — —
Equity attributable to shareholders — 55.8% 49.9% 55.2% 57.1% 55.5% 52.5% 30.3% 40.3% 38.9% — — —
Non-controlling interest — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — —
Total equity — 55.8% 49.9% 55.2% 57.1% 55.5% 52.5% 30.3% 40.3% 38.9% — — —
Total liabilities & equity — 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% — — —
Key figures
Total debt — 18.8% 16.2% 20.7% 21.1% 22.7% 24.8% 27.6% 37.8% 37.5% — — —
Net debt / (net cash) — 9.7% (0.9%) 2.9% 2.6% 6.4% 1.0% 4.3% 32.3% 30.9% — — —
Common equity — 55.8% 49.9% 55.2% 57.1% 55.5% 52.5% 30.3% 40.3% 38.9% — — —

Each line as a percentage of total assets.

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets; "—" = not reported. Updated 16 Oct 2026.

All reported line items 154
BFBIO balance sheet — all reported line items (Rs bn)
Rs bn Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023
Cash & Cash Equivalents — 0.3 0.4 0.3 0.3 0.3 0.2 1.9 0.3 0.3 — —
Cash & Short Term Investments — 0.8 1.7 1.6 1.5 1.3 2.0 1.9 0.3 0.4 — —
Short-Term Investments - Total — 0.5 1.3 1.3 1.2 1.1 1.8 0.0 0.0 0.0 — —
Loans & Receivables - Net - Short-Term 0.4 0.8 0.8 0.8 0.3 0.5 0.4 0.5 0.3 0.3 — —
Loans & Receivables - Total 0.4 0.8 0.8 0.8 0.3 0.5 0.4 0.5 0.3 0.3 — —
Trade Accounts & Trade Notes Receivable - Net — 0.6 0.6 0.6 0.2 0.4 0.3 0.5 0.2 0.2 — —
Trade Accounts & Trade Notes Receivable - Gross 0.4 — — — 0.2 — — — 0.2 0.2 — —
Provision - Trade Accounts & Trade Notes Receivable 0.0 — — — 0.0 — — — 0.0 0.0 — —
Loans - Short-Term 0.0 0.2 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.0 — —
Income Tax - Receivables - Short-Term 0.0 — — — 0.0 — — — 0.0 0.0 — —
Receivables - Other - Total 0.0 — — — 0.0 — — — 0.0 0.0 — —
Accounts & Notes Receivable - Trade - Gross - Total 0.4 — — — 0.2 — — — 0.2 0.2 — —
Inventories - Total 3.3 2.7 2.7 1.8 1.8 1.8 1.5 1.1 0.9 0.9 — —
Inventories - Raw Materials 1.6 0.1 0.1 0.1 1.0 0.2 0.2 0.1 0.6 0.6 — —
Inventories - Work in Progress 0.9 — — — 0.4 — — — 0.2 0.1 — —
Inventories - Finished Goods 0.4 — — — 0.3 — — — 0.1 0.1 — —
Inventories - Other - Total 0.4 2.6 2.6 1.7 0.1 1.6 1.3 1.0 (0.0) 0.1 — —
Prepaid Expenses - Short-Term 0.2 0.2 0.2 0.2 0.2 0.1 0.1 — 0.0 0.0 — —
Investments - Total — 0.5 1.3 1.3 1.2 1.1 1.8 0.0 0.0 0.0 — —
Other Current Assets - Total 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.1 — —
Property, Plant & Equipment - Net - Total — 4.5 4.4 4.3 4.3 4.2 4.3 4.3 4.2 4.1 — —
Restricted Accounts - Short-Term 0.0 — — — 0.1 — — — 0.1 0.1 — —
Property, Plant & Equipment - Gross - Total 5.9 — — — 5.3 — — — 5.0 4.9 — —
Property, Plant & Equipment - Accumulated Depreciation & Impairment - Total 1.2 — — — 1.0 — — — 0.8 0.8 — —
Other Current Assets 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.0 0.0 — —
Other Assets - Total 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.3 0.1 0.1 — —
Intangible Assets - Total - Net — 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — —
Total Current Assets — 4.6 5.5 4.4 3.8 3.9 4.1 3.9 1.7 1.7 — —
Intangible Assets - excluding Goodwill - Net - Total — 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — —
Intangible Assets - Gross - Total 0.0 — — — 0.0 — — — 0.0 0.0 — —
Intangible Assets - excluding Goodwill - Gross 0.0 — — — 0.0 — — — 0.0 0.0 — —
Intangible Assets - Accumulated Amortization & Impairment - Total 0.0 — — — 0.0 — — — 0.0 0.0 — —
Intangible Assets - excluding Goodwill - Accumulated Amortization & Impairment - Total 0.0 — — — 0.0 — — — 0.0 0.0 — —
Computer Software - Intangible Assets - Net — 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — —
Property, Plant & Equipment - excluding Assets Leased Out - Net - Total 4.6 — 4.4 4.3 4.3 4.2 4.3 4.3 4.2 4.1 — —
Land & Buildings - Net 0.7 — — — 0.8 — — — 0.1 0.0 — —
Land/Improvements - Net 0.0 — — — 0.0 — — — 0.0 0.0 — —
Computer Software - Intangible Assets - Gross 0.0 — — — 0.0 — — — 0.0 0.0 — —
Plant, Machinery & Equipment - Net 3.3 — — — 3.4 — — — 0.6 0.1 — —
Transportation Equipment - Net 0.1 — — — 0.1 — — — 0.0 0.0 — —
Computer Software & Equipment - Net 0.0 — — — 0.0 — — — 0.0 0.0 — —
Construction in Progress - Net 0.5 — 0.2 0.1 0.1 0.0 0.1 3.6 3.5 4.0 — —
Property, Plant & Equipment - Other - Net 0.0 — 4.2 4.3 0.0 4.2 4.2 0.7 0.0 0.0 — —
Computer Software - Intangible Assets - Accumulated Amortization & Impairment 0.0 — — — 0.0 — — — 0.0 0.0 — —
Property, Plant & Equipment - excluding Assets Leased Out - Gross 5.9 — — — 5.3 — — — 5.0 4.9 — —
Land & Buildings - Gross 1.0 — — — 1.0 — — — 0.3 0.2 — —
Land/Improvements - Gross 0.0 — — — 0.0 — — — 0.0 0.0 — —
Plant, Machinery & Equipment - Gross 4.3 — — — 4.1 — — — 1.2 0.7 — —
Transportation Equipment - Gross 0.1 — — — 0.1 — — — 0.0 0.0 — —
Computer Software & Equipment - Gross 0.1 — — — 0.0 — — — 0.0 0.0 — —
Construction in Progress - Gross 0.5 — — — 0.1 — — — 3.5 4.0 — —
Total Assets — 9.2 10.0 8.7 8.2 8.2 8.4 8.2 5.9 5.9 — —
Property, Plant & Equipment - Other - Gross 0.0 — — — 0.0 — — — 0.0 0.0 — —
Debt - Total — 1.7 1.6 1.8 1.7 1.9 2.1 2.3 2.2 2.2 — —
Short-Term Debt & Current Portion of Long-Term Debt — 0.6 0.4 0.5 0.4 0.3 0.6 0.7 0.6 0.5 — —
Property, Plant & Equipment - excluding Assets Leased Out - Accumulated Depreciation & Impairment - Total 1.2 — — — 1.0 — — — 0.8 0.8 — —
Land & Buildings - Accumulated Depreciation & Impairment 0.3 — — — 0.2 — — — 0.2 0.2 — —
Land/Improvements - Accumulated Depreciation & Impairment 0.0 — — — 0.0 — — — 0.0 0.0 — —
Current Portion of Long-Term Debt including Capitalized Leases — 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 — —
Plant, Machinery & Equipment - Accumulated Depreciation & Impairment 0.9 — — — 0.7 — — — 0.6 0.6 — —
Transportation Equipment - Accumulated Depreciation & Impairment 0.0 — — — 0.0 — — — 0.0 0.0 — —
Computer Software & Equipment - Accumulated Depreciation & Impairment 0.0 — — — 0.0 — — — 0.0 0.0 — —
Short-Term Debt & Notes Payable — 0.2 0.1 0.1 0.0 0.0 0.2 0.4 0.3 0.2 — —
Debt - Long-Term - Total — 1.2 1.2 1.3 1.4 1.5 1.5 1.6 1.6 1.7 — —
Property, Plant & Equipment - Other - Accumulated Depreciation & Impairment 0.0 — — — 0.0 — — — 0.0 0.0 — —
Current Portion of Long-Term Debt excluding Capitalized Leases — 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 — —
Long-Term Debt excluding Capitalized Leases — 1.2 1.2 1.3 1.4 1.5 1.5 1.6 1.6 1.7 — —
Other Non-Current Assets - Total — 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — —
Debt - Non-Convertible - Long-Term — 1.2 1.2 1.3 1.4 1.5 1.5 1.6 1.6 1.7 — —
Deferred Tax - Asset - Long-Term — — — — — — — — — 0.0 — —
Deferred Tax & Investment Tax Credits - Long-Term — 0.3 0.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 — —
Deferred Tax - Liability - Long-Term — 0.3 0.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 — —
Payables & Accrued Expenses 1.1 1.6 2.6 1.4 0.8 1.1 1.2 1.1 0.5 0.5 — —
Trade Account Payables - Total 0.3 1.6 2.6 1.4 0.3 1.1 1.2 1.1 0.3 0.3 — —
Other Non-Current Assets — 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — —
Accrued Expenses 0.9 — — — 0.5 — — — 0.2 0.3 — —
Total Liabilities — 4.1 5.0 3.9 3.5 3.6 4.0 5.7 3.5 3.6 — —
Shareholders' Equity - Attributable to Parent Shareholders - Total — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Total Non-Current Assets — 4.6 4.5 4.3 4.3 4.3 4.3 4.3 4.2 4.2 — —
Common Equity Attributable to Parent Shareholders — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Common Equity - Contributed — 2.0 2.0 2.0 2.0 2.0 2.0 0.2 0.2 0.2 — —
Common Stock - Issued & Paid — 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.2 0.2 — —
Equity - Non-Contributed - Reserves & Retained Earnings — 3.1 3.0 2.8 2.6 2.5 2.4 2.3 2.2 2.1 — —
Retained Earnings - Total — 3.1 3.0 2.8 2.6 2.5 2.4 2.3 2.2 2.1 — —
Trade Accounts Payable & Accruals - Short-Term 1.1 1.6 2.6 1.4 0.8 1.1 1.2 1.1 0.5 0.5 — —
Trade Accounts & Trade Notes Payable - Short-Term 0.3 1.6 2.6 1.4 0.3 1.1 1.2 1.1 0.3 0.3 — —
Accrued Expenses - Short-Term 0.9 — — — 0.5 — — — 0.2 0.3 — —
Income Taxes - Payable - Short-Term 0.0 — — — 0.0 — — — 0.0 0.0 — —
Other Current Liabilities - Total 0.6 0.1 0.3 0.2 0.5 0.2 0.2 1.9 0.3 0.3 — —
Common Equity - Total — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Deferred Income - Short-Term — 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 0.2 — —
Common Stock - Additional Paid in Capital including Option Reserve — 1.8 1.8 1.8 1.8 1.8 1.8 — — — — —
Total Shareholders' Equity - including Minority Interest & Hybrid Debt — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Total Liabilities & Equity — 9.2 10.0 8.7 8.2 8.2 8.4 8.2 5.9 5.9 — —
Other Current Liabilities 0.4 0.0 0.0 0.0 0.3 0.0 0.0 1.7 0.2 0.2 — —
Total Current Liabilities — 2.3 3.2 2.1 1.6 1.6 2.0 3.7 1.4 1.4 — —
Other Non-Current Liabilities - Total — 0.2 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 — —
Deferred Revenue - Long-Term — 0.2 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 — —
Total Non-Current Liabilities — 1.7 1.8 1.9 1.9 2.0 2.0 2.0 2.1 2.2 — —
Common Shares - Issued - Total mn — 88.3 88.3 88.3 88.3 88.3 88.3 88.3 63.3 63.3 — —
Common Shares - Outstanding - Total mn — 88.3 88.3 88.3 88.3 88.3 88.3 88.3 63.3 63.3 — —
Common Shares - Treasury - Total mn — 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — —
Common Shares - Authorized - Issue Specific mn — 400.0 400.0 400.0 — 400.0 — — — — — —
Common Shares - Issued - Issue Specific mn — 88.3 88.3 88.3 88.3 88.3 88.3 88.3 63.3 63.3 — —
Common Shares - Outstanding - Issue Specific mn — 88.3 88.3 88.3 88.3 88.3 88.3 88.3 63.3 63.3 — —
Common Shares - Treasury - Issue Specific mn — 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — —
Asset Allocation Factor - Issue Specific — 1.00× 1.00× 1.00× 1.00× 1.00× 1.00× 1.00× 1.00× 1.00× — —
Debt including Finance and Operating Lease Liabilities - Supplemental — 1.7 1.6 1.8 1.7 1.9 2.1 2.3 2.2 2.2 — —
Net Debt — 0.9 (0.1) 0.3 0.2 0.5 0.1 0.4 1.9 1.8 — —
Debt - Long-Term - Maturities - Total — — — — — — — — 2.6 2.6 — —
Debt - Long-Term - Maturities - within 1 Year — — — — — — — — 0.5 0.4 — —
Debt - Long-Term - Maturities - Year 5 — — — — — — — — 1.6 1.6 — —
Debt - Long-Term - Maturities - Remaining — — — — — — — — 0.5 0.6 — —
Debt - Long-Term - Maturities - 4-5 Years — — — — — — — — 1.6 1.6 — —
Debt - Long-Term - Maturities - Year 6 & Beyond — — — — — — — — 0.5 0.6 — —
Asset Accruals — 8.9 9.6 8.5 7.8 7.9 8.2 6.3 5.6 5.5 — —
Cash & Cash Equivalents - Total — 0.3 0.4 0.3 0.3 0.3 0.2 1.9 0.3 0.3 — —
Cash & Short Term Investments - Total — 0.8 1.7 1.6 1.5 1.3 2.0 1.9 0.3 0.4 — —
Debt - including Preferred Equity & Minority Interest - Total — 1.7 1.6 1.8 1.7 1.9 2.1 2.3 2.2 2.2 — —
Net Book Capital — 6.0 4.9 5.1 4.9 5.1 4.5 2.8 4.3 4.1 — —
Net Operating Assets — 6.0 4.9 5.1 4.9 5.1 4.5 2.8 4.3 4.1 — —
Provisions - Total — 0.3 0.3 0.2 0.2 0.1 0.1 0.0 0.0 0.0 — —
Shareholders Equity - Common — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Tangible Total Equity — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Tangible Book Value — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Total Book Capital — 6.9 6.6 6.6 6.4 6.4 6.5 4.7 4.6 4.5 — —
Total Capital — 6.9 6.6 6.6 6.4 6.4 6.5 4.7 4.6 4.5 — —
Total Long Term Capital — 6.9 6.8 6.7 6.5 6.6 6.4 4.5 4.4 4.4 — —
Unearned Revenue - Total — 0.4 0.5 0.4 0.5 0.5 0.5 0.6 0.6 0.6 — —
Book Value excluding Other Equity — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Income Taxes - Payable - Long-Term & Short-Term 0.0 — — — 0.0 — — — 0.0 0.0 — —
Revolving Line of Credit - Outstanding — — — — — — — — 0.1 0.0 — —
Revolving Line of Credit - Total Principal Amount — — — — — — — — 1.0 1.0 — —
Contract Liabilities - Short-Term - Advance Consideration & Progress Billings in Excess of Unbilled Revenue — 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 — —
Accruals - Short-Term — 2.0 1.9 2.1 1.9 2.0 1.9 (1.6) (0.0) (0.1) — —
Cash & Short Term Investments - Net of Debt — (0.9) 0.1 (0.3) (0.2) (0.5) (0.1) (0.4) (1.9) (1.8) — —
Current Portion of Long-Term Debt including Capitalized Leases & Hybrid Financial Instruments — 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 — —
Total Fixed Assets - Net — 4.6 4.5 4.3 4.3 4.3 4.3 4.3 4.2 4.2 — —
Working Capital — 2.3 2.3 2.4 2.2 2.3 2.1 0.2 0.2 0.3 — —
Interest Bearing Liabilities - Total — 1.7 1.6 1.8 1.7 1.9 2.1 2.3 2.2 2.2 — —
Working Capital - Non-Cash — 1.5 0.6 0.8 0.7 1.0 0.1 (1.7) (0.1) (0.1) — —
Working Capital excluding Other Current Assets & Liabilities 2.7 2.4 2.4 2.4 2.6 2.4 2.2 1.8 0.5 0.6 — —
Net Debt Including Preferred Equity & Minority Interest — 0.9 (0.1) 0.3 0.2 0.5 0.1 0.4 1.9 1.8 — —
Other Short-Term & Long-Term Assets - Total 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.3 0.0 0.0 — —
Other Short-Term & Long-Term Liabilities - Total 0.6 0.1 0.3 0.2 0.5 0.2 0.2 1.9 0.3 0.3 — —
Total Current Assets excluding Total Inventories 1.2 1.9 2.8 2.6 2.0 2.1 2.6 2.8 0.8 0.8 — —
Tangible Book Value excluding Other Equity — 5.1 5.0 4.8 4.7 4.5 4.4 2.5 2.4 2.3 — —
Total Debt Excluding Islamic — 1.7 1.6 1.8 1.7 1.9 2.1 2.3 2.2 2.2 — —
Trade Accounts & Trade Notes Receivable - Net - Total — 0.6 0.6 0.6 0.2 0.4 0.3 0.5 0.2 0.2 — —
Provision for Doubtful Accounts & Notes Receivable - Total 0.0 — — — 0.0 — — — 0.0 0.0 — —
Current Liabilities excluding Current Debt - Total — 1.8 2.8 1.6 1.3 1.3 1.4 3.0 0.8 0.9 — —
Cash in Hand & with Banks - Total — 0.3 0.4 0.3 0.3 0.3 0.2 1.9 0.3 0.3 — —
Current Assets excluding Cash & Short Term Investments - Total — 3.8 3.8 2.9 2.3 2.6 2.1 2.0 1.4 1.3 — —
Cash, Short Term Investments & Accounts Receivable - Total — 1.4 2.3 2.1 1.7 1.7 2.3 2.4 0.5 0.6 — —

Every line the company reported, in the original order and wording, without regrouping or signs changed. Latest 12 periods; the table above goes back further.